α-Tomatine inhibits growth and induces apoptosis in HL-60 human myeloid leukemia cells. 2015

Huarong Huang, and Shaohua Chen, and Jeremiah Van Doren, and Dongli Li, and Chelsea Farichon, and Yan He, and Qiuyan Zhang, and Kun Zhang, and Allan H Conney, and Susan Goodin, and Zhiyun Du, and Xi Zheng
Allan H. Conney Laboratory for Anticancer Research, Guangdong University of Technology, Guangzhou, Guangdong 510006, P.R. China.

α‑Tomatine is a glycoalkaloid that occurs naturally in tomatoes (Lycopersicon esculentum). In the present study, the effects of α‑tomatine on human myeloid leukemia HL‑60 cells were investigated. Treatment of HL‑60 cells with α‑tomatine resulted in growth inhibition and apoptosis in a concentration‑dependent manner. Tomatidine, the aglycone of tomatine had little effect on the growth and apoptosis of HL‑60 cells. Growth inhibition and apoptosis induced by α‑tomatine in HL‑60 cells was partially abrogated by addition of cholesterol indicating that interactions between α‑tomatine and cell membrane‑associated cholesterol may be important in mediating the effect of α‑tomatine. Activation of nuclear factor‑κB by the phorbol ester, 12‑O‑tetradecanoylphorbol‑13‑acetate failed to prevent apoptosis in HL‑60 cells treated with α‑tomatine. In animal experiments, it was found that treatment of mice with α‑tomatine inhibited the growth of HL‑60 xenografts in vivo. Results from the present study indicated that α‑tomatine may have useful anti‑leukemia activities.

UI MeSH Term Description Entries
D007951 Leukemia, Myeloid Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites. Granulocytic Leukemia,Leukemia, Granulocytic,Leukemia, Myelocytic,Leukemia, Myelogenous,Myelocytic Leukemia,Myelogenous Leukemia,Myeloid Leukemia,Leukemia, Monocytic, Chronic,Monocytic Leukemia, Chronic,Chronic Monocytic Leukemia,Chronic Monocytic Leukemias,Granulocytic Leukemias,Leukemia, Chronic Monocytic,Leukemias, Chronic Monocytic,Leukemias, Granulocytic,Leukemias, Myelocytic,Leukemias, Myelogenous,Leukemias, Myeloid,Monocytic Leukemias, Chronic,Myelocytic Leukemias,Myelogenous Leukemias,Myeloid Leukemias
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013755 Tetradecanoylphorbol Acetate A phorbol ester found in CROTON OIL with very effective tumor promoting activity. It stimulates the synthesis of both DNA and RNA. Phorbol Myristate Acetate,12-Myristoyl-13-acetylphorbol,12-O-Tetradecanoyl Phorbol 13-Acetate,Tetradecanoylphorbol Acetate, 4a alpha-Isomer,12 Myristoyl 13 acetylphorbol,12 O Tetradecanoyl Phorbol 13 Acetate,13-Acetate, 12-O-Tetradecanoyl Phorbol,Acetate, Phorbol Myristate,Acetate, Tetradecanoylphorbol,Myristate Acetate, Phorbol,Phorbol 13-Acetate, 12-O-Tetradecanoyl,Tetradecanoylphorbol Acetate, 4a alpha Isomer
D014053 Tomatine An alkaloid that occurs in the extract of leaves of wild tomato plants. It has been found to inhibit the growth of various fungi and bacteria. It is used as a precipitating agent for steroids. (From The Merck Index, 11th ed)
D014183 Transplantation, Heterologous Transplantation between animals of different species. Xenotransplantation,Heterograft Transplantation,Heterografting,Heterologous Transplantation,Xenograft Transplantation,Xenografting,Transplantation, Heterograft,Transplantation, Xenograft
D016328 NF-kappa B Ubiquitous, inducible, nuclear transcriptional activator that binds to enhancer elements in many different cell types and is activated by pathogenic stimuli. The NF-kappa B complex is a heterodimer composed of two DNA-binding subunits: NF-kappa B1 and relA. Immunoglobulin Enhancer-Binding Protein,NF-kappa B Complex,Nuclear Factor kappa B,Transcription Factor NF-kB,kappa B Enhancer Binding Protein,Ig-EBP-1,NF-kB,NF-kappaB,Nuclear Factor-Kappab,Complex, NF-kappa B,Enhancer-Binding Protein, Immunoglobulin,Factor NF-kB, Transcription,Factor-Kappab, Nuclear,Ig EBP 1,Immunoglobulin Enhancer Binding Protein,NF kB,NF kappa B Complex,NF kappaB,NF-kB, Transcription Factor,Nuclear Factor Kappab,Transcription Factor NF kB

Related Publications

Huarong Huang, and Shaohua Chen, and Jeremiah Van Doren, and Dongli Li, and Chelsea Farichon, and Yan He, and Qiuyan Zhang, and Kun Zhang, and Allan H Conney, and Susan Goodin, and Zhiyun Du, and Xi Zheng
January 2021, Current gene therapy,
Huarong Huang, and Shaohua Chen, and Jeremiah Van Doren, and Dongli Li, and Chelsea Farichon, and Yan He, and Qiuyan Zhang, and Kun Zhang, and Allan H Conney, and Susan Goodin, and Zhiyun Du, and Xi Zheng
November 2001, Acta pharmacologica Sinica,
Huarong Huang, and Shaohua Chen, and Jeremiah Van Doren, and Dongli Li, and Chelsea Farichon, and Yan He, and Qiuyan Zhang, and Kun Zhang, and Allan H Conney, and Susan Goodin, and Zhiyun Du, and Xi Zheng
October 2012, Bioorganic & medicinal chemistry letters,
Huarong Huang, and Shaohua Chen, and Jeremiah Van Doren, and Dongli Li, and Chelsea Farichon, and Yan He, and Qiuyan Zhang, and Kun Zhang, and Allan H Conney, and Susan Goodin, and Zhiyun Du, and Xi Zheng
May 2009, Journal of pineal research,
Huarong Huang, and Shaohua Chen, and Jeremiah Van Doren, and Dongli Li, and Chelsea Farichon, and Yan He, and Qiuyan Zhang, and Kun Zhang, and Allan H Conney, and Susan Goodin, and Zhiyun Du, and Xi Zheng
August 2004, Life sciences,
Huarong Huang, and Shaohua Chen, and Jeremiah Van Doren, and Dongli Li, and Chelsea Farichon, and Yan He, and Qiuyan Zhang, and Kun Zhang, and Allan H Conney, and Susan Goodin, and Zhiyun Du, and Xi Zheng
June 2005, Leukemia research,
Huarong Huang, and Shaohua Chen, and Jeremiah Van Doren, and Dongli Li, and Chelsea Farichon, and Yan He, and Qiuyan Zhang, and Kun Zhang, and Allan H Conney, and Susan Goodin, and Zhiyun Du, and Xi Zheng
April 1994, Blood,
Huarong Huang, and Shaohua Chen, and Jeremiah Van Doren, and Dongli Li, and Chelsea Farichon, and Yan He, and Qiuyan Zhang, and Kun Zhang, and Allan H Conney, and Susan Goodin, and Zhiyun Du, and Xi Zheng
June 1998, Yao xue xue bao = Acta pharmaceutica Sinica,
Huarong Huang, and Shaohua Chen, and Jeremiah Van Doren, and Dongli Li, and Chelsea Farichon, and Yan He, and Qiuyan Zhang, and Kun Zhang, and Allan H Conney, and Susan Goodin, and Zhiyun Du, and Xi Zheng
January 2019, Drug design, development and therapy,
Huarong Huang, and Shaohua Chen, and Jeremiah Van Doren, and Dongli Li, and Chelsea Farichon, and Yan He, and Qiuyan Zhang, and Kun Zhang, and Allan H Conney, and Susan Goodin, and Zhiyun Du, and Xi Zheng
December 1999, Biological & pharmaceutical bulletin,
Copied contents to your clipboard!